Rx Update: Xtoro (Finafloxacin Otic Suspension)
Xtoro by Alcon Laboratories, approved December 17, 2014, is a quinolone antimicrobial indicated for the treatment of acute otitis externa caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus. Prolonged use of Xtoro may lead to overgrowth of nonsusceptible organisms. Allergic reactions may occur in patients with a history of hypersensitivity to finafloxacin, other quinolones, or any of the components in this medication. Cross-resistance has been observed between finafloxacin and other fluoroquinolones but not between finafloxacin and other classes of antibacterial agents. Patients should be advised that if a rash or allergic reaction occurs, they should discontinue the use of the product immediately and contact their physician.
Before administration of Xtoro, patients or caregivers should warm the bottle by holding it in their hands for 1 or 2 minutes to avoid dizziness that may result from the instillation of a cold solution. Xtoro is administered by instilling 4 drops in the affected ear(s) twice daily for 7 days. For patients requiring use of an ear wick, the initial dose can be doubled (to 8 drops), followed by 4 drops instilled into the affected ear twice daily for 7 days.
Dosage form and strength: 5 mL of finafloxacin otic suspension, 0.3%, in an 8-mL bottle. Xtoro is a Pregnancy Category C medication. The most common adverse reactions, occurring in 1% of patients, were ear pruritus and nausea.
Source: Xtoro prescribing information.
Knock Out Aches and Pains From Cold
October 30th 2019The symptoms associated with colds, most commonly congestion, coughing, sneezing, and sore throats, are the body's response when a virus exerts its effects on the immune system. Cold symptoms peak at about 1 to 2 days and last 7 to 10 days but can last up to 3 weeks.
COPD: Should a Clinician Treat or Refer?
October 27th 2019The Global Initiative for Chronic Obstructive Lung Disease (GOLD) defines the condition as follows: “COPD is a common, preventable, and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases.â€
Diabetic Ketoacidosis Is Preventable With Proper Treatment
October 24th 2019Cancer, diabetes, and heart disease account for a large portion of the $3.3 trillion annual US health care expenditures. In fact, 90% of these expenditures are due to chronic conditions. About 23 million people in the United States have diabetes, 7 million have undiagnosed diabetes, and 83 million have prediabetes.
What Are the Latest Influenza Vaccine Recommendations?
October 21st 2019Clinicians should recommend routine yearly influenza vaccinations for everyone 6 months or older who has no contraindications for the 2019-2020 influenza season starting at the end of October, according to the Advisory Committee on Immunization Practices.
What Is the Best Way to Treat Pharyngitis?
October 18th 2019There are many different causes of throat discomfort, but patients commonly associate a sore throat with an infection and may think that they need antibiotics. This unfortunately leads to unnecessary antibiotic prescribing when clinicians do not apply evidence-based practice.
